Form 4: ALX Oncology SVP, Finance and CAO, Shelly Pinto, Sells Shares to Cover Tax Obligations

Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 564 shares of common stock on August 14, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• On August 14, 2024, Shelly Pinto, the SVP, Finance and CAO of ALX Oncology Holdings Inc., sold 564 shares of common stock.
• The shares were sold at a price of $2.58 per share.
• The sale was executed to satisfy tax obligations related to the vesting of restricted stock units.
• Following the transaction, Pinto directly owns 91,549 shares of ALX Oncology Holdings Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors. The sale appears to be related to tax obligations, which is a typical reason for insider sales.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates